On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenﾒs Health Research, an effort led…
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
On Oct. 7, 2023, California became the first state to ban four chemicals used in well-known candies and…
On Sept. 27, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that new diagnoses of…
On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…
On Sept. 6, 2023, the Markey Cancer Center (MCC) became Kentucky’s first and only National Cancer Institute (NCI)-Designated…
On Aug. 31, 2023, the U.S. Food and Drug Administration (FDA) cleared for marketing the updated 23andMe Personal…
On Aug. 16, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved over…
On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
On May 1, 2023, an Oregon Health Sciences University (OHSU) dermatologist and a multi-disciplinary team confirmed that a…
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
On Mar. 23, 2023, the Fred Hutchinson Cancer Center (FHCRC) announced a new building in South Lake Union…
On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
On Feb. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a major step forward…
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
On Jan. 6, 2023, the Purdue Center for Cancer Research announced it was changing its name to the…
On Dec. 24, 2022, the U.S. Food and Drug Administration (FDA) approved updated labeling for Genentech’s capecitabine tablets…
On Dec. 9, 2022, the U.S. Food and Drug Administration (FDA) approved Genentech’s atezolizumab (Tecentriq) for adult and…
On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment…
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
On Oct. 26, 2022, the Barbara Ann Karmanos Cancer Institute announced it had completed an over 50,000-square-foot expansion…
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…
On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…
May 27, 2022, the National Cancer Institute (NCI) truncated the just-renewed five-year Cancer Center Support Grant held by…
On Apr. 6, 2022, a new study in the Journal of Clinical Oncology showed that women receiving certain…
On Apr. 1, 2022, the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) announced a…